백신 전달 장치 시장 규모, 점유율, 동향 분석 보고서 : 장치별, 투여 경로별, 지역별, 부문 예측(2025-2030년)

Vaccine Delivery Devices Market Growth & Trends:

The global vaccine delivery devices market size is anticipated to reach USD 11.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 7.6% from 2024 to 2030. The market is primarily driven by growing immunization programs, financial support from government and non-government organizations, increasing vaccination initiatives and campaigns, and the rising prevalence of infectious diseases globally. Growing research in the field of vaccines and the development of new products are also contributing to the growth of the market.

The adoption of a needle-free approach for administering these products is gaining momentum due to the growing awareness and demand to avoid pain and injuries associated with the use of a needle stick. Data by the Centers for Disease Control and Prevention states that an estimated 385,000 sharp injuries including needle stick injuries occur every year in hospitals in the U.S. Advancing technologies in administering vaccines and their increasing adoption is propelling the market growth. The rising interest of various key players, national institutions, and organizations in novel delivery technologies is expected to further contribute to market growth.

The Covid-19 epidemic significantly boosted the market growth, especially due to the increasing demand for vaccination to tackle the spread of the virus. Increasing investment in Research & Development by vaccination device manufacturers as well as the governments has expanded the market significantly at an accelerated pace. Initiatives are undertaken by various regulatory authorities like UNICEF, Gavi, and WHO are also expected to boost the market growth.

Various governments and international organizations are increasingly investing in the development of vaccination programs. For instance, the U.K. government also announced funding of up to £1 million from its Global Challenges Research Fund through Medical Research Council to investigate the Zika virus and its transmission. Organizations such as GAVI Alliance, Bill & Melinda Gates Foundation, Path, and the WHO are actively involved in the field of vaccines. Many governments are also undertaking several immunization programs on priority.

Vaccine Delivery Devices Market Report Highlights:

• By device, the syringes segment held the largest revenue share in 2024 due to the increasing vaccination programs, spreading immunization coverage, and technological advancements
• By route of administration, intradermal vaccination dominated the market in 2024 as the majority of vaccines are given through this route owing to its advantages
• North America dominated the global market in 2024 owing to the increasing awareness levels, high adoption of technology, and the rising prevalence of infectious diseases

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Device
  • 1.2.2. Route of Administration
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Device outlook
  • 2.2.2. Route of Administration outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Vaccine Delivery Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Vaccine Delivery Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Vaccine Delivery Devices Market: Device Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Vaccine Delivery Devices Market: Device Movement Analysis
• 4.3. Vaccine Delivery Devices Market by Device Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Syringes
  • 4.5.1. Syringes Vaccine Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Jet Injectors
  • 4.6.1. Jet Injectors Vaccine Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Vaccine Delivery Devices Market: Route of Administration Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Vaccine Delivery Devices Market: Route of Administration Movement Analysis
• 5.3. Vaccine Delivery Devices Market by Route of Administration Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Intradermal Vaccination
  • 5.5.1. Intradermal Vaccination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Intramuscular Vaccination
  • 5.6.1. Intramuscular Vaccination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Subcutaneous Vaccination
  • 5.7.1. Subcutaneous Vaccination Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Vaccine Delivery Devices Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Vaccine Delivery Devices Market Movement Analysis
• 6.3. Vaccine Delivery Devices Market: Regional Estimates & Trend Analysis 2018 to 2030 for the following
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. North America
  • 6.5.1. North America Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1 Key Country Dynamics
    • 6.5.2.2 Competitive Scenario
    • 6.5.2.3 Regulatory Framework
    • 6.5.2.4 Reimbursement scenario
    • 6.5.2.5 U.S. Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1 Key Country Dynamics
    • 6.5.3.2 Competitive Scenario
    • 6.5.3.3 Regulatory Framework
    • 6.5.3.4 Reimbursement scenario
    • 6.5.3.5 Canada Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1 Key Country Dynamics
    • 6.5.4.2 Competitive Scenario
    • 6.5.4.3 Regulatory Framework
    • 6.5.4.4 Reimbursement scenario
    • 6.5.4.5 Mexico Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1 Key Country Dynamics
    • 6.6.2.2 Competitive Scenario
    • 6.6.2.3 Regulatory Framework
  • 6.6.24 Reimbursement scenario
    • 6.6.2.5 UK Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1 Key Country Dynamics
    • 6.6.3.2 Competitive Scenario
    • 6.6.3.3 Regulatory Framework
    • 6.6.3.4 Reimbursement scenario
    • 6.6.3.5 Germany Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. France
    • 6.6.4.1 Key Country Dynamics
    • 6.6.4.2 Competitive Scenario
    • 6.6.4.3 Regulatory Framework
    • 6.6.4.4 Reimbursement scenario
    • 6.6.4.5 France Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1 Key Country Dynamics
    • 6.6.5.2 Competitive Scenario
    • 6.6.5.3 Regulatory Framework
    • 6.6.5.4 Reimbursement scenario
    • 6.6.5.5 Italy Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1 Key Country Dynamics
    • 6.6.6.2 Competitive Scenario
    • 6.6.6.3 Regulatory Framework
    • 6.6.6.4 Reimbursement scenario
    • 6.6.6.5 Spain Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Denmark
    • 6.6.7.1 Key Country Dynamics
    • 6.6.7.2 Competitive Scenario
    • 6.6.7.3 Regulatory Framework
    • 6.6.7.4 Reimbursement scenario
    • 6.6.7.5 Denmark Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1 Key Country Dynamics
    • 6.6.8.2 Competitive Scenario
    • 6.6.8.3 Regulatory Framework
    • 6.6.8.4 Reimbursement scenario
    • 6.6.8.5 Sweden Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.9. Norway
    • 6.6.9.1 Key Country Dynamics
    • 6.6.9.2 Competitive Scenario
    • 6.6.9.3 Regulatory Framework
    • 6.6.9.4 Reimbursement scenario
    • 6.6.9.5 Norway Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Asia Pacific Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Japan
    • 6.7.2.1 Key Country Dynamics
    • 6.7.2.2 Competitive Scenario
    • 6.7.2.3 Regulatory Framework
    • 6.7.2.4 Reimbursement scenario
    • 6.7.2.5 Japan Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. China
    • 6.7.3.1 Key Country Dynamics
    • 6.7.3.2 Competitive Scenario
    • 6.7.3.3 Regulatory Framework
    • 6.7.3.4 Reimbursement scenario
    • 6.7.3.5 China Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.4. India
    • 6.7.4.1 Key Country Dynamics
    • 6.7.4.2 Competitive Scenario
    • 6.7.4.3 Regulatory Framework
    • 6.7.4.4 Reimbursement scenario
    • 6.7.4.5 India Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1 Key Country Dynamics
    • 6.7.5.2 Competitive Scenario
    • 6.7.5.3 Regulatory Framework
    • 6.7.5.4 Reimbursement scenario
    • 6.7.5.5 South Korea Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.6. Australia
    • 6.7.6.1 Key Country Dynamics
    • 6.7.6.2 Competitive Scenario
    • 6.7.6.3 Regulatory Framework
    • 6.7.6.4 Reimbursement scenario
    • 6.7.6.5 Australia Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.7. Thailand
    • 6.7.7.1 Key Country Dynamics
    • 6.7.7.2 Competitive Scenario
    • 6.7.7.3 Regulatory Framework
    • 6.7.7.4 Reimbursement scenario
    • 6.7.7.5 Thailand Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Latin America Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. Brazil
    • 6.8.2.1 Key Country Dynamics
    • 6.8.2.2 Competitive Scenario
    • 6.8.2.3 Regulatory Framework
    • 6.8.2.4 Reimbursement scenario
    • 6.8.2.5 Brazil Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1 Key Country Dynamics
    • 6.8.3.2 Competitive Scenario
    • 6.8.3.3 Regulatory Framework
    • 6.8.3.4 Reimbursement scenario
    • 6.8.3.5 Argentina Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.9. Middle East & Africa
  • 6.9.1. Middle East & Africa Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.2. South Africa
    • 6.9.2.1 Key Country Dynamics
    • 6.9.2.2 Competitive Scenario
    • 6.9.2.3 Regulatory Framework
    • 6.9.2.4 Reimbursement scenario
    • 6.9.2.5 South Africa Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1 Key Country Dynamics
    • 6.9.30.2 Competitive Scenario
    • 6.9.3.3 Regulatory Framework
    • 6.9.3.4 Reimbursement scenario
    • 6.9.3.5 Saudi Arabia Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.4. UAE
    • 6.9.4.1 Key Country Dynamics
    • 6.9.4.2 Competitive Scenario
    • 6.9.4.3 Regulatory Framework
    • 6.9.4.4 Reimbursement scenario
    • 6.9.4.5 UAE Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1 Key Country Dynamics
    • 6.9.5.2 Competitive Scenario
    • 6.9.52.3 Regulatory Framework
    • 6.9.5.4 Reimbursement scenario
    • 6.9.5.5 Kuwait Vaccine Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. BD
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. PharmaJet
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. . Vaxxas
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Gerresheimer AG
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. SCHOTT AG
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Corium International, Inc.
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. 3M
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives